Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
OxyContin maker Purdue Pharma could be dissolved and replaced by a company focused on the public good by the end of the week, as a massive legal settlement resolving thousands of lawsuits is set to take effect. A federal judge on Tuesday is…
OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
Email Address: I agree to the Terms and Conditions, Cookie and Privacy Policies, and CASL agreement. Already have an account? Log in here - To continue reading, please subscribe: Enjoy unlimited reading on winnipegfreepress.com Read the E-Edition…
Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial
Company announcement – No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people living with…
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
Organon (OGN +16.87%), a women's health therapies specialist, closed Monday at $13.16, up 16.87%. The stock is jumping after premarket news that Sun Pharmaceutical Industries agreed to acquire Organon in an all-cash deal. Trading volume reached…
Nuvectis Pharma (NVCT) Projected to Post Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) is anticipated to post its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect Nuvectis Pharma to post earnings of ($0.30) per share for the quarter. Individuals may review…
BridgeBio Pharma (NASDAQ:BBIO) Earns 'Outperform' Rating from Mizuho
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report)'s stock had its 'outperform' rating reaffirmed by Mizuho in a note issued to investors on Tuesday, Benzinga reports. They currently have a $106.00 price objective on the stock. Mizuho's target price…
Pharmalittle: We're reading about warnings over Trump's MFN plan, Purdue Pharma sentencing, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where clear blue skies and pleasant breezes are greeting us. Who could ask for anything more? Actually, we could —…
BridgeBio Pharma (BBIO) Expected to Announce Earnings on Tuesday
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) is expected to be releasing its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect BridgeBio Pharma to post earnings of ($0.71) per share and revenue of $178.6280 million…
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - Here's What Happened
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) gapped up prior to trading on Tuesday. The stock had previously closed at $74.52, but opened at $83.20. BridgeBio Pharma shares last traded at $80.6210, with a volume of 1,592,131…
Teacher Retirement System of Texas Lowers Position in Royalty Pharma PLC $RPRX
Teacher Retirement System of Texas cut its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 33.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…
Novartis Could Upgrade Future Growth Outlook
backed its 2026 guidance and raised the prospect of upgrading its mid- to long-term growth outlook as it receives data in the second half of the year from multiple drug trials. The Swiss pharmaceutical company said Tuesday that competition from…
Indian Stock Market Decline: Oil Price, FII Outflows, Banking Sector Woes
Indian stock markets, including the Sensex and Nifty, experienced a notable decline driven by surging crude oil prices, significant foreign institutional investor (FII) outflows, and regulatory pressures on the banking sector. Indian benchmark…
Pharmaceutical company suddenly buries new factory in Muttenz
A major industrial project in Baselland is off the table: Corden Pharma is stopping the construction of a new chemical plant in Muttenz. Behind the scenes, there are many indications that US trade policy under Donald Trump played a decisive role.
Stock markets decline amid surging oil prices, foreign fund outflows
Stock market benchmark indices Sensex and Nifty buckled under selling pressure on Tuesday (April 28, 2026) as a sharp rally in oil prices and foreign fund outflows dented investors' sentiment. The 30-share BSE Sensex declined 416.72 points, or…
Boehringer Ingelheim's Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows
Boehringer Ingelheim said it had promising late-stage trial results for an obesity drug designed to safeguard muscle mass while targeting fat, as the German pharma company vies for a spot in the burgeoning market for weight-loss treatments.
Receive a Daily briefing on Pharma Industry News
Get Started